About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 15236 record(s)
Req # A-2024-001072
Adverse Drug Reaction (ADR) for Chlorhexinde Gluconate. Report number: E2B_07229838.Organization: Health Canada
February 2025
Req # A-2024-001169
Adverse Drug Reaction (ADR). Report number: 001101763.Organization: Health Canada
February 2025
Req # A-2024-001229
Adverse Drug Reactions (ADRs). Report numbers: E2B_07351864, E2B_07352987, E2B_07500310.Organization: Health Canada
February 2025
Req # A-2024-001235
Adverse Drug Reaction (ADR). Report number: E2B_06249974.Organization: Health Canada
February 2025
Req # A-2024-001238
Adverse Drug Reaction (ADR). Report number: E2B_06248803.Organization: Health Canada
February 2025
Req # A-2024-001239
Adverse Drug Reaction (ADR). Report number: E2B_06529593.Organization: Health Canada
February 2025
Req # A-2024-001240
Adverse Drug Reaction (ADR). Report number: E2B_05211789.Organization: Health Canada
February 2025
Req # A-2024-001302
Adverse Drug Reaction (ADR). Report number: E2B_02449951.Organization: Health Canada
February 2025
Req # A-2024-001354
Adverse Drug Reaction (ADR). Report number: E2B_02564624.Organization: Health Canada
February 2025
Req # A-2024-001369
Adverse Drug Reaction (ADR). Report number: E2B_05066063.Organization: Health Canada
February 2025